Healthcare -
Biotechnology - NASDAQ - NL
$ 46.42
-1.42 %
$ 3.21 B
Market Cap
-13.86
P/E
Price Target
Average
74.99%
Revenue Forecast
Estimate
116.06%
EBIT
Estimate
--41.47%
Net Income
Estimate
16.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Merus N.V.
Wall Street analysts predict an average 1-year price target for MRUS of $81.2 , with forecasts ranging from
a
low of
$58 to a high of $99 .
MRUS Lowest Price Target
Wall Street Target
58 USD
24.95%
MRUS Average Price Target
Wall Street Target
81.2 USD
74.99%
MRUS Highest Price Target
Wall Street Target
99 USD
113.27%
REVENUE FORECAST
Revenue Forecast Chart MRUS
EBIT FORECAST
EBIT Forecast Chart MRUS
NET INCOME FORECAST
Net Income Chart MRUS